Business Description
Susmed Inc
ISIN : JP3319150003
Description
Susmed Inc is engaged in the development of medical equipment and software systems Collection and distribution of medical information.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.94 | |||||
| Interest Coverage | 111.3 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 17.79 | |||||
| Beneish M-Score | -2.41 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 143.4 | |||||
| 3-Year EBITDA Growth Rate | 36.8 | |||||
| 3-Year EPS without NRI Growth Rate | 21.5 | |||||
| 3-Year Book Growth Rate | 134.1 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 65.62 | |||||
| 9-Day RSI | 57.81 | |||||
| 14-Day RSI | 51.97 | |||||
| 6-1 Month Momentum % | -62.55 | |||||
| 12-1 Month Momentum % | -65.62 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 15.8 | |||||
| Quick Ratio | 15.8 | |||||
| Cash Ratio | 15.64 | |||||
| Days Inventory | 333.97 | |||||
| Days Sales Outstanding | 6.3 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -2.3 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 98.68 | |||||
| Operating Margin % | 5.96 | |||||
| Net Margin % | 6.59 | |||||
| FCF Margin % | 11.25 | |||||
| ROE % | 1 | |||||
| ROA % | 0.95 | |||||
| ROIC % | 23.36 | |||||
| ROCE % | 0.9 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 190.23 | |||||
| PE Ratio without NRI | 180.71 | |||||
| PS Ratio | 12.42 | |||||
| PB Ratio | 1.89 | |||||
| Price-to-Tangible-Book | 1.89 | |||||
| Price-to-Free-Cash-Flow | 109.28 | |||||
| Price-to-Operating-Cash-Flow | 89.52 | |||||
| EV-to-EBIT | 94.01 | |||||
| EV-to-EBITDA | 94.01 | |||||
| EV-to-Revenue | 5.6 | |||||
| EV-to-FCF | 49.78 | |||||
| Price-to-Graham-Number | 3.9 | |||||
| Price-to-Net-Current-Asset-Value | 1.91 | |||||
| Price-to-Net-Cash | 1.93 | |||||
| Earnings Yield (Greenblatt) % | 1.06 | |||||
| FCF Yield % | 0.9 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Susmed Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil 円) | 732.673 | ||
| EPS (TTM) (円) | 2.886 | ||
| Beta | 0 | ||
| Volatility % | 65.18 | ||
| 14-Day RSI | 51.97 | ||
| 14-Day ATR (円) | 21.733931 | ||
| 20-Day SMA (円) | 539.8 | ||
| 12-1 Month Momentum % | -65.62 | ||
| 52-Week Range (円) | 504 - 1823 | ||
| Shares Outstanding (Mil) | 16.73 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Susmed Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Susmed Inc Stock Events
| Event | Date | Price(円) | ||
|---|---|---|---|---|
| No Event Data | ||||
Susmed Inc Frequently Asked Questions
What is Susmed Inc(TSE:4263)'s stock price today?
The current price of TSE:4263 is 円549.00. The 52 week high of TSE:4263 is 円1823.00 and 52 week low is 円504.00.
When is next earnings date of Susmed Inc(TSE:4263)?
The next earnings date of Susmed Inc(TSE:4263) is .
Does Susmed Inc(TSE:4263) pay dividends? If so, how much?
Susmed Inc(TSE:4263) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers